# Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia

> **NCT03602053** · PHASE2,PHASE3 · COMPLETED · sponsor: **Centre for Infectious Disease Research in Zambia** · enrollment: 450 (actual)

## Conditions studied

- Diarrhea
- Diarrhea Rotavirus

## Interventions

- **BIOLOGICAL:** ROTAVAC®
- **BIOLOGICAL:** ROTAVAC 5D
- **BIOLOGICAL:** Rotarix®

## Key facts

- **NCT ID:** NCT03602053
- **Lead sponsor:** Centre for Infectious Disease Research in Zambia
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-01-22
- **Primary completion:** 2019-10-04
- **Final completion:** 2019-10-04
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2020-12-19

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03602053

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03602053, "Study of BBIL's ROTAVAC® and ROTAVAC 5CM Vaccines in Zambia". Retrieved via AI Analytics 2026-05-30 from https://api.ai-analytics.org/clinical/NCT03602053. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*